Revance Therapeutics shares owned by UBS O'Connor
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by UBS O'Connor
from 13F filings
Historical chart of UBS O'Connor investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by UBS O'Connor
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $1.0M | 89k | 11.47 |
| 2023-03-31 | $651k | 20k | 32.21 |
| 2022-12-31 | $72k | 189k | 0.38 |
| 2022-09-30 | $97k | 201k | 0.48 |
| 2022-06-30 | $344k | 275k | 1.25 |
| 2022-03-31 | $475k | 190k | 2.50 |